lenalidomide has been researched along with Leukemia, Pre-B-Cell in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Abro, B; Barnell, EK; Campbell, KM; Chavez, M; Cotto, KC; Duncavage, EJ; Fiala, MA; Frater, JL; Griffith, M; Griffith, OL; Hassan, A; King, JA; Kohnen, DR; Kreisel, F; Lee, YS; Newcomer, KF; Parikh, BA; Ruzinova, MB; Skidmore, ZL; Spies, NC; Uy, GL; Vij, K; Vij, R; Wang, T; Wartman, LD; Welch, JS | 1 |
| Bhatnagar, B; Dilip, D; Geyer, MB; Glass, JL; Hassoun, H; Klein, V; Landau, H; Lozanski, G; Mims, AS; Park, JH; Roshal, M; Shaffer, BC; Xiao, W; Zhang, Y | 1 |
| Arévalo, CE; Arnan, M; Arribas, I; Baca, C; Bosch, A; Carro, I; Gamundi, E; Granada, I; Maluquer, C; Montané, C; Pomares, H; Ribes-Amorós, J; Sureda, A; Zamora, L | 1 |
| Aboulafia, DM; Hwang, DG; Peterson, JF; Sinit, RB; Vishnu, P | 1 |
| Anderson, LD; Chen, W; Fuda, FS; Gagan, J; Germans, SK; Jaso, JM; Koduru, P; Kulak, O; Oliver, D; Patel, P | 1 |
| Khoury, JD; Tashakori, M | 1 |
| Bostrom, B; Vundamati, D | 1 |
3 review(s) available for lenalidomide and Leukemia, Pre-B-Cell
| Article | Year |
|---|---|
B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature.
Topics: Humans; Lenalidomide; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Thalidomide | 2023 |
B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Bone Marrow; Humans; Immunologic Factors; Lenalidomide; Male; Multiple Myeloma; Neoplasms, Second Primary; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Thalidomide | 2019 |
Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma-A Unique Entity.
Topics: Adult; Antineoplastic Agents; Bone Marrow; Cytogenetic Analysis; Fatal Outcome; High-Throughput Nucleotide Sequencing; Humans; Immunologic Factors; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Neoplasm, Residual; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Stem Cell Transplantation | 2020 |
4 other study(ies) available for lenalidomide and Leukemia, Pre-B-Cell
| Article | Year |
|---|---|
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma.
Topics: Bone Marrow; Burkitt Lymphoma; Humans; Immunoglobulin Heavy Chains; In Situ Hybridization, Fluorescence; Lenalidomide; Multiple Myeloma; Mutation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2023 |
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal.
Topics: Aged; Burkitt Lymphoma; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Multiple Myeloma; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Progression-Free Survival; Retrospective Studies | 2023 |
B acute lymphoblastic leukemia arising during maintenance therapy for multiple myeloma.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Autografts; Female; Humans; Lenalidomide; Maintenance Chemotherapy; Multiple Myeloma; Neoplasms, Second Primary; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation | 2020 |
Prolonged Response in Patient With Multiply Relapsed B-cell Acute Lymphoblastic Leukemia and Monosomy-7 to Bortezomib, Lenalidomide, and Dexamethasone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Child; Chromosome Deletion; Chromosomes, Human, Pair 7; Dexamethasone; Female; Humans; In Situ Hybridization, Fluorescence; Lenalidomide; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Thalidomide | 2016 |